An observational study of patients with emerging or established severe cerebral vasospasm after subarachnoid haemorrhage, employing multimodal neuromonitoring.
Study Type
OBSERVATIONAL
Enrollment
200
Induced hypertension with norepinephrine and/or dobutamine to attain clinically established goals of cerebral perfusion pressure in a stepwise fashion, according to clinical routine.
Endoluminal spasmolysis of cerebral arteries using i.a. Nimodipine, according to clinical protocol and neurointerventionist discretion.
Karolinska University Hospital
Stockholm, Sweden
RECRUITINGMean Flow Velocity (MFV)
Increase or decrease of Mean Flow Velocity of the medial cerebral artery as determined by Transcranial Doppler.
Time frame: Up to 12 hours post intervention
Duration of MFV change after Endoluminal Spasmolysis
Time until Mean Flow Velocity, as determined by Transcranial Doppler, returns to or surpasses baseline.
Time frame: Up to 12 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.